-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Initiates Coverage On OKYO Pharma with Overweight Rating, Announces Price Target of $7

Benzinga·02/20/2026 10:09:07
Listen to the news
Piper Sandler analyst Biren Amin initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Overweight rating and announces Price Target of $7.